These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 32705214

  • 1. A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells.
    Zhang R, Chen X, Fu S, Xu L, Lin J.
    Oncol Rep; 2020 Sep; 44(3):1224-1232. PubMed ID: 32705214
    [Abstract] [Full Text] [Related]

  • 2. A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin.
    Zhang R, Yang X, Roque DM, Li C, Lin J.
    PLoS One; 2021 Sep; 16(4):e0240145. PubMed ID: 33909625
    [Abstract] [Full Text] [Related]

  • 3. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
    Lin L, Hutzen B, Li PK, Ball S, Zuo M, DeAngelis S, Foust E, Sobo M, Friedman L, Bhasin D, Cen L, Li C, Lin J.
    Neoplasia; 2010 Jan; 12(1):39-50. PubMed ID: 20072652
    [Abstract] [Full Text] [Related]

  • 4. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
    Onimoe GI, Liu A, Lin L, Wei CC, Schwartz EB, Bhasin D, Li C, Fuchs JR, Li PK, Houghton P, Termuhlen A, Gross T, Lin J.
    Invest New Drugs; 2012 Jun; 30(3):916-26. PubMed ID: 21340507
    [Abstract] [Full Text] [Related]

  • 5. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
    Tang YJ, Sun ZL, Wu WG, Xing J, He YF, Xin DM, Han P.
    Genet Mol Res; 2015 Mar 30; 14(1):2450-60. PubMed ID: 25867391
    [Abstract] [Full Text] [Related]

  • 6. A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.
    Lin L, Benson DM, DeAngelis S, Bakan CE, Li PK, Li C, Lin J.
    Int J Cancer; 2012 Mar 15; 130(6):1459-69. PubMed ID: 21520044
    [Abstract] [Full Text] [Related]

  • 7. Anti-angiogenic activity of a small molecule STAT3 inhibitor LLL12.
    Bid HK, Oswald D, Li C, London CA, Lin J, Houghton PJ.
    PLoS One; 2012 Mar 15; 7(4):e35513. PubMed ID: 22530037
    [Abstract] [Full Text] [Related]

  • 8. Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.
    Wei CC, Ball S, Lin L, Liu A, Fuchs JR, Li PK, Li C, Lin J.
    Int J Oncol; 2011 Jan 15; 38(1):279-85. PubMed ID: 21109950
    [Abstract] [Full Text] [Related]

  • 9. LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells.
    Chen X, Pan L, Wei J, Zhang R, Yang X, Song J, Bai RY, Fu S, Pierson CR, Finlay JL, Li C, Lin J.
    Sci Rep; 2021 Mar 22; 11(1):6517. PubMed ID: 33753770
    [Abstract] [Full Text] [Related]

  • 10. The small molecule, LLL12, inhibits STAT3 phosphorylation and induces apoptosis in medulloblastoma and glioblastoma cells.
    Ball S, Li C, Li PK, Lin J.
    PLoS One; 2011 Apr 19; 6(4):e18820. PubMed ID: 21526200
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.
    Abubaker K, Luwor RB, Zhu H, McNally O, Quinn MA, Burns CJ, Thompson EW, Findlay JK, Ahmed N.
    BMC Cancer; 2014 May 06; 14():317. PubMed ID: 24886434
    [Abstract] [Full Text] [Related]

  • 12. KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.
    Chen Y, Johnson JD, Jayamohan S, He Y, Venkata PP, Jamwal D, Alejo S, Zou Y, Lai Z, Viswanadhapalli S, Vadlamudi RK, Kost E, Sareddy GR.
    Mol Carcinog; 2024 Oct 06; 63(10):2026-2039. PubMed ID: 38990091
    [Abstract] [Full Text] [Related]

  • 13. Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines.
    Couto JI, Bear MD, Lin J, Pennel M, Kulp SK, Kisseberth WC, London CA.
    BMC Vet Res; 2012 Dec 17; 8():244. PubMed ID: 23244668
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells.
    Zhong Y, Le F, Cheng J, Luo C, Zhang X, Wu X, Xu F, Zuo Q, Tan B.
    Oncol Rep; 2021 May 17; 45(5):. PubMed ID: 33760192
    [Abstract] [Full Text] [Related]

  • 17. Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids.
    Hossein G, Halvaei S, Heidarian Y, Dehghani-Ghobadi Z, Hassani M, Hosseini H, Naderi N, Sheikh Hassani S.
    Cancer Med; 2019 Aug 17; 8(9):4315-4329. PubMed ID: 31197964
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.